(Q49012858)

17 February 2018

title

Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. (English)

1 reference

17 February 2018

4

Haass C

1 reference

17 February 2018

author name string

Qiu WQ

1

1 reference

17 February 2018

Borth W

2

1 reference

17 February 2018

Ye Z

3

1 reference

17 February 2018

Teplow DB

5

1 reference

17 February 2018

Selkoe DJ

6

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 April 1996

1 reference

17 February 2018

Journal of Biological Chemistry

published in

1 reference

17 February 2018

volume

271

1 reference

17 February 2018

issue

14

1 reference

17 February 2018

page(s)

8443-8451

1 reference

17 February 2018

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Genetic and molecular advances in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

alpha 2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Inhibitors of kallikrein in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Generation of an esterolytic and kinin-forming kallikrein-?2-macroglobulin complex in human serum by treatment with acetone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

A novel endopeptidase from Xenopus that recognizes alpha-helical secondary structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Electrophoretic techniques for the analysis of synthetic amyloid beta-A4-related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

The major component of a large, intracellular proteinase accumulated by inhibitors is a complex of α 2-macroglobulin and thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.14.8443

21 January 2018

Identifiers

DOI

10.1074/JBC.271.14.8443

1 reference

17 February 2018

1 reference

17 February 2018